National Peroxide Ltd — Dividend/Bonus, 12-08-2026: Corp. Action

National Peroxide's board approved revised financial results for the quarter and financial year ended March 31, 2026, and unaudited results for the quarter ended June 30, 2026. The revision rectified an accounting error that understated raw material costs by ₹6.95 Cr and overstated previous profits. The board maintained its final dividend of ₹7 per equity share for FY26, pending shareholder approval. The 6th Annual General Meeting is scheduled for September 29, 2026, to also consider the re-appointment of statutory auditors.